BioAffinity Technologies Inc. (BIAF)
NASDAQ · Healthcare
BioAffinity Technologies Inc. Income Statement 2022–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|
| Revenues | ||||
| Revenue | 6.2M | 9.4M | 2.5M | 4,803 |
| Gross Profit | — | — | — | 4,336 |
| Profitability | ||||
| Operating Income | -10.6M | -9.0M | -8.0M | -4.0M |
| EBITDA | -10.1M | -8.3M | -7.7M | -4.0M |
| Net Income | -14.9M | -9.0M | -7.9M | -8.2M |
| Per Share Data | ||||
| EPS (diluted) | — | — | — | — |
| Shares Outstanding (dil.) | 2M | 0M | 9M | 4M |
BioAffinity Technologies Inc. Income Statement — FAQ
BioAffinity Technologies Inc. (BIAF) income statement over the last 4 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BIAF's income statement history?
The chart and table above show BioAffinity Technologies Inc.'s income statement by year and by quarter, including the growth rate.